The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2017

Filed:

Mar. 03, 2015
Applicant:

Uwm Research Foundation, Inc., Milwaukee, WI (US);

Inventors:

James M. Cook, Milwaukee, WI (US);

Terry S. Clayton, Colorado Springs, CO (US);

Hiteshkumar D. Jain, Mumbai, IN;

Yun Teng Johnson, Glendale, WI (US);

Jie Yang, Renssalaer, NY (US);

Sundari K. Rallipalli, Oak Creek, WI (US);

Zhi-jian Wang, Whitefish Bay, WI (US);

Ojas A. Namjoshi, Cary, NC (US);

Michael Ming-Jin Poe, Milwaukee, WI (US);

Assignee:

UWM Research Foundation, Inc., Milwaukee, WI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/551 (2006.01); C07D 487/04 (2006.01); A61K 31/695 (2006.01); C07D 487/14 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/695 (2013.01); A61K 31/551 (2013.01); C07D 487/04 (2013.01); C07D 487/14 (2013.01); C07D 519/00 (2013.01);
Abstract

Described herein are α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands, pharmaceutical compositions, and methods of use of such ligands and compositions in treatment of anxiety disorders, epilepsy and schizophrenia with reduced sedative and ataxic side effects. In embodiments, such as α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands lack ester linkages and may be thus relatively insensitive to hydrolysis by esterases.


Find Patent Forward Citations

Loading…